KPRX
Price
$3.08
Change
-$0.01 (-0.32%)
Updated
Jun 6 closing price
Capitalization
9.41M
RNAC
Price
$11.04
Change
+$1.69 (+18.09%)
Updated
Jun 6 closing price
Capitalization
243.45M
Interact to see
Advertisement

KPRX vs RNAC

Header iconKPRX vs RNAC Comparison
Open Charts KPRX vs RNACBanner chart's image
Kiora Pharmaceuticals
Price$3.08
Change-$0.01 (-0.32%)
Volume$231.86K
Capitalization9.41M
Cartesian Therapeutics
Price$11.04
Change+$1.69 (+18.09%)
Volume$100.18K
Capitalization243.45M
KPRX vs RNAC Comparison Chart
Loading...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPRX vs. RNAC commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPRX is a StrongBuy and RNAC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (KPRX: $3.00 vs. RNAC: $9.09)
Brand notoriety: KPRX and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPRX: 87% vs. RNAC: 89%
Market capitalization -- KPRX: $9.41M vs. RNAC: $243.45M
KPRX [@Biotechnology] is valued at $9.41M. RNAC’s [@Biotechnology] market capitalization is $243.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPRX’s FA Score shows that 3 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • KPRX’s FA Score: 3 green, 2 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, KPRX is a better buy in the long-term than RNAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPRX’s TA Score shows that 4 TA indicator(s) are bullish while RNAC’s TA Score has 5 bullish TA indicator(s).

  • KPRX’s TA Score: 4 bullish, 6 bearish.
  • RNAC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RNAC is a better buy in the short-term than KPRX.

Price Growth

KPRX (@Biotechnology) experienced а -3.54% price change this week, while RNAC (@Biotechnology) price change was -2.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($243M) has a higher market cap than KPRX($9.41M). KPRX has higher P/E ratio than RNAC: KPRX (3.67) vs RNAC (1.76). KPRX YTD gains are higher at: -9.091 vs. RNAC (-49.246). KPRX has higher annual earnings (EBITDA): 2.39M vs. RNAC (-75.99M). RNAC has more cash in the bank: 213M vs. KPRX (29M). KPRX has less debt than RNAC: KPRX (72.6K) vs RNAC (14M). RNAC has higher revenues than KPRX: RNAC (38.9M) vs KPRX (16M).
KPRXRNACKPRX / RNAC
Capitalization9.41M243M4%
EBITDA2.39M-75.99M-3%
Gain YTD-9.091-49.24618%
P/E Ratio3.671.76209%
Revenue16M38.9M41%
Total Cash29M213M14%
Total Debt72.6K14M1%
FUNDAMENTALS RATINGS
KPRX vs RNAC: Fundamental Ratings
KPRX
RNAC
OUTLOOK RATING
1..100
6456
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
33100
PRICE GROWTH RATING
1..100
8295
P/E GROWTH RATING
1..100
162
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPRX's Valuation (24) in the Pharmaceuticals Other industry is significantly better than the same rating for RNAC (99) in the Biotechnology industry. This means that KPRX’s stock grew significantly faster than RNAC’s over the last 12 months.

KPRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as RNAC (100) in the Biotechnology industry. This means that KPRX’s stock grew similarly to RNAC’s over the last 12 months.

KPRX's SMR Rating (33) in the Pharmaceuticals Other industry is significantly better than the same rating for RNAC (100) in the Biotechnology industry. This means that KPRX’s stock grew significantly faster than RNAC’s over the last 12 months.

KPRX's Price Growth Rating (82) in the Pharmaceuticals Other industry is in the same range as RNAC (95) in the Biotechnology industry. This means that KPRX’s stock grew similarly to RNAC’s over the last 12 months.

KPRX's P/E Growth Rating (1) in the Pharmaceuticals Other industry is somewhat better than the same rating for RNAC (62) in the Biotechnology industry. This means that KPRX’s stock grew somewhat faster than RNAC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPRXRNAC
RSI
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
79%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
87%
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
88%
Advances
ODDS (%)
Bullish Trend 24 days ago
79%
Bullish Trend about 1 month ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 18 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
89%
Bullish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
89%
Bullish Trend 12 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

KPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPRX has been closely correlated with CDTX. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if KPRX jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
+1.35%
CDTX - KPRX
90%
Closely correlated
-5.46%
NCNA - KPRX
90%
Closely correlated
-3.85%
RNAC - KPRX
89%
Closely correlated
+3.65%
NBY - KPRX
89%
Closely correlated
-0.58%
WINT - KPRX
89%
Closely correlated
+5.12%
More

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
+3.65%
WINT - RNAC
94%
Closely correlated
+5.12%
NCNA - RNAC
92%
Closely correlated
-3.85%
NBY - RNAC
91%
Closely correlated
-0.58%
SNPX - RNAC
91%
Closely correlated
-10.74%
SNGX - RNAC
89%
Closely correlated
+1.05%
More